Skip to main content

Phase I trial of lenalidomide in combination with plerixafor for relapsed/refractory chronic lymphocytic leukemia (CLL): follow-up and correlative analysis

Publication ,  Conference
Brander, D; Weinberg, JB; Friedman, D; Stewart, T; Rizzieri, D
Published in: LEUKEMIA & LYMPHOMA
December 1, 2017

Duke Scholars

Published In

LEUKEMIA & LYMPHOMA

EISSN

1029-2403

ISSN

1042-8194

Publication Date

December 1, 2017

Volume

58

Start / End Page

35 / 37

Publisher

TAYLOR & FRANCIS LTD

Related Subject Headings

  • Immunology
  • 3201 Cardiovascular medicine and haematology
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Brander, D., Weinberg, J. B., Friedman, D., Stewart, T., & Rizzieri, D. (2017). Phase I trial of lenalidomide in combination with plerixafor for relapsed/refractory chronic lymphocytic leukemia (CLL): follow-up and correlative analysis. In LEUKEMIA & LYMPHOMA (Vol. 58, pp. 35–37). TAYLOR & FRANCIS LTD.
Brander, Danielle, J Brice Weinberg, Daphne Friedman, Tiffany Stewart, and David Rizzieri. “Phase I trial of lenalidomide in combination with plerixafor for relapsed/refractory chronic lymphocytic leukemia (CLL): follow-up and correlative analysis.” In LEUKEMIA & LYMPHOMA, 58:35–37. TAYLOR & FRANCIS LTD, 2017.
Brander D, Weinberg JB, Friedman D, Stewart T, Rizzieri D. Phase I trial of lenalidomide in combination with plerixafor for relapsed/refractory chronic lymphocytic leukemia (CLL): follow-up and correlative analysis. In: LEUKEMIA & LYMPHOMA. TAYLOR & FRANCIS LTD; 2017. p. 35–7.
Brander, Danielle, et al. “Phase I trial of lenalidomide in combination with plerixafor for relapsed/refractory chronic lymphocytic leukemia (CLL): follow-up and correlative analysis.” LEUKEMIA & LYMPHOMA, vol. 58, TAYLOR & FRANCIS LTD, 2017, pp. 35–37.
Brander D, Weinberg JB, Friedman D, Stewart T, Rizzieri D. Phase I trial of lenalidomide in combination with plerixafor for relapsed/refractory chronic lymphocytic leukemia (CLL): follow-up and correlative analysis. LEUKEMIA & LYMPHOMA. TAYLOR & FRANCIS LTD; 2017. p. 35–37.

Published In

LEUKEMIA & LYMPHOMA

EISSN

1029-2403

ISSN

1042-8194

Publication Date

December 1, 2017

Volume

58

Start / End Page

35 / 37

Publisher

TAYLOR & FRANCIS LTD

Related Subject Headings

  • Immunology
  • 3201 Cardiovascular medicine and haematology
  • 1103 Clinical Sciences